Insiders · Profile

Goldman Jonathan

Director at Avalo Therapeutics. Filing since 14 Nov 2025. CIK 0002013869

Company

Date

Role

Action

Shares

Amount

Of holding

AVTX Avalo Therapeutics, Inc.

14 Nov 2025

Director

Sold at will

11,367

$162.94K

100%

1 decision on file.